U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

microRNAs and their target proteins are associated with characteristics of estrogen receptor-positive breast cancer (miRNA data)

(Submitter supplied) Recent analyses have identified heterogeneity in estrogen receptor (ER)-positive breast cancer. There are so-called luminal A and luminal B subtypes, and the characteristics, such as response to endocrine therapy and chemotherapy and prognosis, are different in these two subtypes of breast cancer. In this study, expression profiles of microRNAs (miRNAs) and mRNAs in ER-positive breast cancer tissues were compared between highly and incompletely endocrine responsive tumors by miRNA and mRNA microarrays. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL13746
8 Samples
Download data: GPR
Series
Accession:
GSE38278
ID:
200038278
2.

microRNAs and their target proteins are associated with characteristics of estrogen receptor-positive breast cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array; Expression profiling by array
Platforms:
GPL5639 GPL13746
16 Samples
Download data: GPR
Series
Accession:
GSE38280
ID:
200038280
3.

microRNAs and their target proteins associated with characteristics of estrogen receptor-positive breast cancer (mRNA data)

(Submitter supplied) Recent analyses have identified heterogeneity in estrogen receptor (ER)-positive breast cancer. There are so-called luminal A and luminal B subtypes, and the characteristics, such as response to endocrine therapy and chemotherapy and prognosis, are different in these two subtypes of breast cancer. In this study, expression profiles of microRNAs (miRNAs) and mRNAs in ER-positive breast cancer tissues were compared between highly and incompletely endocrine responsive tumors by miRNA and mRNA microarrays. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5639
8 Samples
Download data: GPR
Series
Accession:
GSE38279
ID:
200038279
4.

Gene Expression Profiling of Primary Male Breast Cancers Reveals Two Unique Subgroups and Identifies N-acetyltransferase-1 (NAT1) as a Novel Prognostic Biomarker

(Submitter supplied) Male breast cancer (MBC) is a rare and inadequately characterized disease. The aim of the present study was to characterize MBC tumors transcriptionally, to classify them into comprehensive subgroups, and to compare them with female breast cancer (FBC). Methods: Sixty-six clinicopathologically well-annotated fresh frozen MBC tumors were analyzed using Illumina Human HT-12 bead arrays, and a tissue microarray with 220 MBC tumors was constructed for validation using immunohistochemistry. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6947
74 Samples
Download data: TXT
Series
Accession:
GSE31259
ID:
200031259
5.

Expression profiling of circulating miRNAs in Luminal A breast cancer

(Submitter supplied) Breast cancer is a common disease with distinct tumor subtypes which can be phenotypically characterized by estrogen receptor, progesterone receptor and HER2/neu receptor status. MiRNAs play regulatory roles in tumor initiation and progression. Altered miRNA expression has been demonstrated in a variety of cancer states to date presenting the potential for exploitation as cancer specific biomarkers. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platforms:
GPL17040 GPL17039
28 Samples
Download data: TXT
Series
Accession:
GSE46355
ID:
200046355
6.

Comparative cistromics reveals genomic crosstalk between FOXA1 and ERα in tamoxifen-associated endometrial carcinomas

(Submitter supplied) Tamoxifen, which is used to treat breast cancer, increases the risks of endometrial cancer. In this study, we performed a genome-wide assessment of ERα-chromatin interactions in surgical specimens obtained from patients with tamoxifen-associated endometrial cancer. ERα was found at active enhancers in endometrial cancer cells as marked by the presence of RNA polymerase II and the histone marker H3K27Ac. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL11154
23 Samples
Download data: TXT
Series
Accession:
GSE81213
ID:
200081213
7.

183 breast tumors from the Helsinki Univerisity Central Hospital with survival information

(Submitter supplied) 183 breast tumors from the Helsinki Univerisity Central Hospital with survival information
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6947
183 Samples
Download data: TXT
Series
Accession:
GSE24450
ID:
200024450
8.

Expression data from MCF-7 cells transfected with miR-26a and treated or not with estradiol

(Submitter supplied) Altered expression of microRNAs (miRNAs), an abundant class of small non-protein-coding RNAs that mostly function as negative regulators of protein-coding gene expression, is common in cancer. Here we analyze the regulation of miRNA expression in response to estrogen, a steroid hormone that is involved in the development and progression of breast carcinomas and that is acting via the estrogen receptors (ER) transcription factors. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5175
9 Samples
Download data: CEL
Series
Accession:
GSE17460
ID:
200017460
9.

Identification of differently expressed miRNAs between Tamoxifen sensitive cells and Tamoxifen resistant cells

(Submitter supplied) Tamoxifen is the most widely administered adjuvant first-line hormone therapy for Estrogen receptor α (ERα) positive breast cancer patients. However, one from three patients will develop resistance, while the underlying molecular mechanisms are currently unclear. Recent studies reported that abnormal expression of miRNAs played a role in cancer progress. To study the potential function of miRNAs in tamoxifen resistance, Affymetrix GeneChip® miRNA 3.0 microarray was employed to identify differentially expressed miRNAs between tamoxifen sensitive MCF7 parent (MCF7-Pa) cells and induced resistant (MCF7-Re) cells.
Organism:
synthetic construct; Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL16384
2 Samples
Download data: CEL
Series
Accession:
GSE66607
ID:
200066607
10.

Integrated microRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer II

(Submitter supplied) Triple negative breast cancer (TNBC) includes basal and non-basal subclasses. To further stratify TNBC we determined microRNA (miRNA) and mRNA expression profiles, linked specific miRNA signatures to patient survival and used miRNA/mRNA anti-correlations to identify TNBC subclasses associated with expression of canonical signal pathways
Organism:
Homo sapiens
Type:
Expression profiling by array; Non-coding RNA profiling by array
Platforms:
GPL16299 GPL16231
536 Samples
Download data: TXT
Series
Accession:
GSE45498
ID:
200045498
11.

Integrated microRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer

(Submitter supplied) Triple negative breast cancer (TNBC) includes basal and non-basal subclasses. To further stratify TNBC we determined microRNA (miRNA) and mRNA expression profiles, linked specific miRNA signatures to patient survival and used miRNA/mRNA anti-correlations to identify TNBC subclasses associated with expression of canonical signal pathways
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array; Expression profiling by array
Platforms:
GPL16299 GPL16231
329 Samples
Download data: TXT
Series
Accession:
GSE41970
ID:
200041970
12.

Contribution of HSD17B12 for estradiol biosynthesis in human breast cancer

(Submitter supplied) 17beta-hydroxysteroid dehydrogenase type12 (HSD17B12) has been demonstrated to be involved in regulation of in situ biosynthesis of estradiol (E2). HSD17B12 expression was reported in breast carcinomas but its functions have remained unknown. Therefore, we examined the correlation between mRNA expression profiles determined by microarray analysis and tissue E2 concentrations obtained from 16 postmenopausal breast carcinoma cases in order to analyze an association of the enzyme expression with intratumoral E2 production. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL96 GPL97
32 Samples
Download data: CEL, CHP
Series
Accession:
GSE11965
ID:
200011965
13.

MicroRNA sequence and expression analysis in breast tumors by deep sequencing [mRNA expression array data]

(Submitter supplied) MicroRNAs (miRNAs) regulate many genes critical for tumorigenesis. We profiled miRNAs from 11 normal breast tissues, 17 non-invasive, 151 invasive breast carcinomas, and 6 cell lines by in-house-developed barcoded Solexa sequencing. miRNAs were organized in genomic clusters representing promoter-controlled miRNA expression and sequence families representing seed-sequence-dependent miRNA-target regulation. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL3676
161 Samples
Download data: TXT
Series
Accession:
GSE29174
ID:
200029174
14.

MicroRNA sequence and expression analysis in breast tumors by deep sequencing [miRNA sequence data]

(Submitter supplied) MicroRNAs (miRNAs) regulate many genes critical for tumorigenesis. We profiled miRNAs from 11 normal breast tissues, 17 non-invasive, 151 invasive breast carcinomas, and 6 cell lines by in-house-developed barcoded Solexa sequencing. miRNAs were organized in genomic clusters representing promoter-controlled miRNA expression and sequence families representing seed-sequence-dependent miRNA-target regulation. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL10999
245 Samples
Download data: TXT
Series
Accession:
GSE29173
ID:
200029173
15.

MicroRNA sequence and expression analysis in breast tumors by deep sequencing

(Submitter supplied) MicroRNAs (miRNAs) regulate many genes critical for tumorigenesis. We profiled miRNAs from 11 normal breast tissues, 17 non-invasive, 151 invasive breast carcinomas, and 6 cell lines by in-house-developed barcoded Solexa sequencing. miRNAs were organized in genomic clusters representing promoter-controlled miRNA expression and sequence families representing seed-sequence-dependent miRNA-target regulation. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing; Expression profiling by array
Platforms:
GPL10999 GPL3676
406 Samples
Download data: TXT
16.

The prognostic significance of the dynamic changes of miRNA expression in locally advanced BC during neo-adjuvant chemotherapy treatment

(Submitter supplied) Introduction: MicroRNAs (miRNAs) are small non-coding RNA that play a vital role in cancer progression. Neo-adjuvant chemotherapy (NAC) has become the standard of care for locally advanced breast cancer. The aim of this study was to evaluate miRNA alterations during NAC using multiple samples of tissue and serum to correlate miRNA expression with clinico-pathological features and patient outcomes. Methods: Tissue and serum samples were collected from patients with locally advanced breast cancer undergoing NAC at four time points: time of diagnosis, after the first and fourth cycle of doxorubicin/cyclophosphamide treatment, and after the fourth cycle of docetaxel administration. more...
Organism:
synthetic construct; Homo sapiens
Type:
Expression profiling by array
Platform:
GPL14613
66 Samples
Download data: CEL, XLSX
Series
Accession:
GSE70754
ID:
200070754
17.

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer

(Submitter supplied) Tamoxifen is the most widely prescribed anti-estrogen treatment for patients with ER-positive breast cancer. However, there is still a need for biomarkers that reliably predict endocrine sensitivity in breast cancers and these may well be expressed in a dynamic manner. In this study we assessed gene expression changes at multiple time points (days 1, 2, 4, 7, 14) after tamoxifen treatment in the ER-positive ZR-75-1 xenograft model that displays significant changes in apoptosis, proliferation and angiogenesis within 2 days of therapy. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL506
32 Samples
Download data: TXT
Series
Accession:
GSE22386
ID:
200022386
18.

Gene profile of breast cancers with immunohistochemical phenotypes of ER+/- and/or HER2+/-

(Submitter supplied) Hormones and growth factors accelerate cell proliferation of breast cancer cells, and these molecules are well investigated targets for drug development and application. The mechanisms of cell proliferation of breast cancers lacking estrogen receptor (ER) and HER2 have not been fully understood. The purpose of the present study is to find genes that are differentially expressed in breast cancers and that might significantly contribute to cell proliferation in these cancers. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8300
40 Samples
Download data: CEL, XLSX
Series
Accession:
GSE6367
ID:
200006367
19.

Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand inducible growth state

(Submitter supplied) Despite the role of the estrogen receptor alpha (ERalpha) pathway as a key growth driver for breast cells, the phenotypic consequence of exogenous introduction of ERalpha into ERalpha-negative cells paradoxically has been growth inhibition. We map the binding profiles of ERalpha and its interacting transcription factors (TFs), FOXA1 and GATA3 in MCF-7 breast carcinoma cells. We observe that these three TFs form a functional enhanceosome and cooperatively modulate the transcriptional networks previously ascribed to ERalpha alone. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6883
36 Samples
Download data: TXT
Series
Accession:
GSE30574
ID:
200030574
20.

Cellular reprogramming by the conjoint action of ERalpha, FOXA1 and GATA3 to a ligand-inducible growth state

(Submitter supplied) Despite the role of the estrogen receptor alpha (ERalpha) pathway as a key growth driver for breast cells, the phenotypic consequence of exogenous introduction of ERalpha into ERalpha-negative cells paradoxically has been growth inhibition. We map the binding profiles of ERalpha and its interacting transcription factors (TFs), FOXA1 and GATA3, in MCF-7 breast carcinoma cells. We observe that these three TFs form a functional enhanceosome and cooperatively modulate the transcriptional networks previously ascribed to ERalpha alone. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL9115
4 Samples
Download data: BED, TXT
Series
Accession:
GSE29073
ID:
200029073
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_674951be4e6f392e263a57ad|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center